Smardová J
Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Neoplasma. 1999;46(2):80-8.
Alteration of the p53 tumor suppressor gene is the most common genetic defect known to occur in human tumors. Germ-line p53 mutations significantly increase the risk of developing diverse malignancies. FASAY is a simple functional assay for germ-line and somatic mutations in the p53 gene altering the transactivation capability of the p53 protein. The method was successfully used for mutation analysis of p53 in various cell lines, somatic tumor cells and blood cells. In addition, FASAY was also found effective as a tool for basic research of binding of mutant p53 proteins to promoters of different p53 target genes.
p53肿瘤抑制基因的改变是已知在人类肿瘤中发生的最常见的基因缺陷。种系p53突变显著增加了发生多种恶性肿瘤的风险。FASAY是一种用于检测p53基因种系和体细胞突变的简单功能分析方法,这些突变会改变p53蛋白的反式激活能力。该方法已成功用于各种细胞系、体细胞肿瘤细胞和血细胞中p53的突变分析。此外,FASAY还被发现是一种有效的工具,可用于研究突变型p53蛋白与不同p53靶基因启动子结合的基础研究。